Bengt Julander appointed chairman of the board at Pharmalink

Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the board of directors, replacing Anders Wiklund.

Mr Julander is a founder of Pharmalink and was chairman from 1991-2009, after which time he remained as director on the board of the company. He is a member of the board of several listed and private life sciences companies, including Medcap, Stille, Sedana Medical, Unimedic and Proequo.

Johan Häggblad, managing director of Pharmalink, said: “We thank Anders Wiklund for his considerable contribution to Pharmalink’s development. He has been a valued board member and Chairman, and has contributed to the success of the company by providing counsel based on his extensive industry experience. Pharmalink has two late-stage products with significant commercial potential. As we progress these programs we anticipate an even greater focus on corporate development. Bengt Julander’s election as chairman will further strengthen our experienced management team’s effort to execute on our strategy to grow the business rapidly in the coming years.”